12/18
08:14 am
scyx
SCYNEXIS Initiates Dosing in Phase 1 Trial of SCY-247, a Second-Generation Fungerp Candidate for Invasive Fungal Infections [Yahoo! Finance]
Medium
Report
SCYNEXIS Initiates Dosing in Phase 1 Trial of SCY-247, a Second-Generation Fungerp Candidate for Invasive Fungal Infections [Yahoo! Finance]
12/18
08:00 am
scyx
SCYNEXIS Initiates Dosing in Phase 1 Trial of SCY-247, a Second-Generation Fungerp Candidate for Invasive Fungal Infections
Medium
Report
SCYNEXIS Initiates Dosing in Phase 1 Trial of SCY-247, a Second-Generation Fungerp Candidate for Invasive Fungal Infections
11/8
11:07 pm
scyx
SCYNEXIS, Inc. (NASDAQ: SCYX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
SCYNEXIS, Inc. (NASDAQ: SCYX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
11/8
06:19 am
scyx
SCYNEXIS Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Low
Report
SCYNEXIS Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
11/6
04:43 pm
scyx
SCYNEXIS Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
SCYNEXIS Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/6
04:30 pm
scyx
SCYNEXIS Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Medium
Report
SCYNEXIS Reports Third Quarter 2024 Financial Results and Provides Corporate Update
10/10
08:00 am
scyx
SCYNEXIS to Participate in the 2024 Maxim Healthcare Virtual Summit
Low
Report
SCYNEXIS to Participate in the 2024 Maxim Healthcare Virtual Summit